                         SEQUENCE LISTING


<110>  STC.UNM

       Trujillo, Kristina
       Gannon, Nichalas Patrick
       Vaughan, Roger Alan 


<120>  IRISIN-RELATED CANCER TREATMENTS


<130>  N12-269PCT

<140>  Filed Herewith
<141>  Filed Herewith

<150>  62/082,460 
<151>  2014-11-20


<160>  3  
 


<170>  PatentIn version 3.5



<210>  1
<211>  112
<212>  PRT
<213>  Artificial 

<220>
<223>  non-modified irisin

<400>  1

Asp Ser Pro Ser Ala Pro Val Asn Val Thr Val Arg His Leu Lys Ala
1               5                   10                  15

Asn Ser Ala Val Val Ser Trp Asp Val Leu Glu Asp Glu Val Val Ile
            20                  25                  30

Gly Phe Ala Ile Ser Gln Gln Lys Lys Asp Val Arg Met Leu Arg Phe
        35                  40                  45

Ile Gln Glu Val Asn Thr Thr Thr Arg Ser Cys Ala Leu Trp Asp Leu
    50                  55                  60

Glu Glu Asp Thr Glu Gly Ile Val His Val Gln Ala Ile Ser Ile Gln
65                  70                  75                  80

Gly Gln Ser Pro Ala Ser Glu Pro Val Leu Phe Lys Thr Pro Arg Glu 
                85                  90                  95

Ala Glu Lys Met Ala Ser Lys Asn Lys Asp Glu Val Thr Met Lys Glu
            100                 105                 110


<210>  2
<211>  111
<212>  PRT
<213>  Artificial 

<220>
<223>  non-modified irisin variant

<400>  2

Ser Pro Ser Ala Pro Val Asn Val Thr Val Arg His Leu Lys Ala Asn
1               5                   10                  15

Ser Ala Val Val Ser Trp Asp Val Leu Glu Asp Glu Val Val Ile Gly
            20                  25                  30 

Phe Ala Ile Ser Gln Gln Lys Lys Asp Val Arg Met Leu Arg Phe Ile
        35                  40                  45

Gln Glu Van Asn Thr Thr Thr Arg Ser Cys Ala Leu Trp Asp Leu Glu
    50                  55                  60 

Glu Asp Thr Glu Gly Ile Val His Val Gln Ala Ile Ser Ile Gln Glu
65                  70                  75                  80

Gln Ser Pro Ala Ser Glu Pro Val Leu Phe Lys Thr Pro Arg Glu Ala
                85                  90                  95

Glu Lys Met Ala Ser Lys Asn Lys Asp Glu Val Thr Met Lys Glu
            100                 105                 110



<210>  3
<211>  117
<212>  PRT
<213>  Artificial 

<220>
<223>  aegss irisin polypeptide

<400>  3

Ala Glu Gly Ser Ser Asp Ser Pro Ser Ala Pro Val Asn Val Thr Val
1               5                   10                  15

Arg His Leu Lys Ala Asn Ser Ala Val Val Ser Trp Asp Val Leu Glu
            20                  25                  30

Asp Glu Val Val Ile Gly Phe Ala Ile Ser Gln Gln Lys Lys Asp Val
        35                  40                  45 

Arg Met Leu Arg Phe Ile Gln Glu Val Asn Thr Thr Thr Arg Ser Cys
    50                  55                  60  

Ala Leu Trp Asp Leu Glu Glu Asp Thr Glu Tyr Ile Val His Val Gln
65                  70                  75                  80

Ala Ile Ser Ile Gln Gly Gln Ser Pro Ala Ser Glu Pro Val Leu Phe
                85                  90                  95

Lys Thr Pro Arg Glu Ala Glu Lys Met Ala Ser Lys Asn Lys Asp Glu
            100                 105                 110

Val Thr Met Lys Glu
        115

